Federal contract award
36C77025P0048
PHARMACEUTICALS 760-25-1-050-0022 - LEAVENWORTH CMOP AMLODIPINE (VA-25-00014183)
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Veterans Affairs |
| Office | NATIONAL CMOP OFFICE (36C770) |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | Not reported |
| Set-aside | SMALL BUSINESS SET ASIDE - TOTAL |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $29.3K |
| Current contract value | $29.3K |
| Potential contract value / ceiling | $29.3K |
| Start date | Feb 26, 2025 |
| Current end date | Mar 12, 2025 |
| Potential end date | Mar 12, 2025 |
| Latest award activity | Mar 26, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Mar 26, 2025 | P00001 | $2.7K | PHARMACEUTICALS 760-25-1-050-0022 - LEAVENWORTH CMOP AMLODIPINE (VA-25-00014183) |
| Feb 26, 2025 | 0 | $26.6K | PHARMACEUTICALS 760-25-1-050-0022 - LEAVENWORTH CMOP AMLODIPINE (VA-25-00014183) |
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| Jeffrey A Blackard | TCF Intern | jeffrey.blackard@va.gov | Source | Mar 10, 2025 |
| Jeffrey A Blackard | TCF Intern | jeffrey.blackard@va.gov | Source | Mar 10, 2025 |
| Jeffrey A Blackard | TCF Intern | jeffrey.blackard@va.gov | Source | Oct 30, 2024 |
| Blackard, Jeffrey A. | TCF Intern | Jeffrey.Blackard@va.gov (913) 684-0142 | Source | Oct 30, 2024 |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.